ALB and hepatocellular carcinoma: For patients treated with DAA or IFN, common HCC predictors included higher fibrosis stages, older age, male sex, higher AFP levels, and lower albumin or platelet levels [14,26,27,28,29,30,31], consistent with our Cox regression model.